New insights into the mechanism of action of lantibiotics -: diverse biological effects by binding to the same molecular target
New insights into the mechanism of action of lantibiotics -: diverse biological effects by binding to the same molecular target
复制标题
DOI:
10.1093/jac/46.1.1
复制
发表时间:
2000-07-01
影响因子:
5.2
通讯作者:
Sahl, HG
中科院分区:
文献类型:
--
作者:
Brötz, H;Sahl, HG
Leading articles peptidoglycan synthesis assays, mersacidin and actagardine block transglycosylation, the enzyme reaction by which the sugar chains of the peptidoglycan are polymerized. 11 (Figure 2a). In order to investigate the molecular basis for this inhibition, the substrate of the transglycosylase, the membrane-bound peptidoglycan precursor undecaprenyldiphosphoryl-N-acetylmuramic acid–(pentapeptide)-N-acetylglucosamine (lipid II) was purified from bacterial membranes. Binding studies revealed that mersacidin and actagardine form a tight complex with lipid II which differs greatly from the vancomycin–lipid II complex, but equally blocks access of the transglycosylase to its substrate. 8 In the case of the type A lantibiotics, the situation is more complex. First hints on the bactericidal mechanism of nisin were obtained by Ramseier, 12 who observed efflux of UV-absorbing material from treated bacteria and suggested a detergent-like effect. Subsequent studies demonstrated that the addition of type A lantibiotics to susceptible cells leads to the leakage of radiolabelled markers, such as rubidium, amino acids and nucleotides, from the cytoplasm and to the immediate dissipation of the membrane potential. 6, 13 Upon treatment with type A lantibiotics, all biosynthetic processes cease instantly, which is in clear contrast to the selective inhibition of peptidoglycan biosynthesis by the type B lantibiotics. These results strongly indicated that type A lantibiotics destroy the integrity of the cytoplasmic membrane, although experimental evidence excluded a generalized detergent-like solubilization. 14 Investigations with a variety of physiological and artificial membrane systems followed in order to investigate the nature of the membrane disorder. In studies with black lipid membranes (artificial bilayers made of selected phospholipids), type A lantibiotics formed distinct, short-lived pores across the membrane when external voltage was applied. 15 Nuclear magnetic resonance data indicate that, upon contact with phospholipid micelles, type A lantibiotics adopt a conformation such that the side chains of cationic amino acids extend to one side of the peptide and interact with the negatively charged phospholipid head groups, whereas the hydrophobic residues align themselves at the opposite side and become immersed in the membrane core. 16, 17 On the basis of such structural data and of various studies with cytoplasmic membrane vesicles, artificial liposomes and micelles, the following model was proposed for the pore-forming process. 18, 19 Pore formation is initiated by the electrostatic attraction of the cationic type A lantibiotics to the negatively charged phospholipids. 20 Upon insertion into the membrane the lantibiotics are presumed to orient themselves perpendicularly to the membrane and, since they do not lose contact with the phospholipids in the course of this rearrangement, they bend the bilayer and force a transient pore to open (Figure 2b). The driving force for this process is thought to be provided by the membrane potential, as it is generated by